Osteoporosis, vitamin D deficiency, and supplementation in juvenile systemic lupus erythematosus: comment on the article by Compeyrot-Lacassagne et al.
Sonja
S
Praprotnik
Matija
M
Tomsic
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects / Q000502:physiology; D002118:Calcium / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D019587:Dietary Supplements; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D010024:Osteoporosis / Q000209:etiology* / Q000517:prevention & control*; D012307:Risk Factors; D014807:Vitamin D / Q000008:administration & dosage / Q000627:therapeutic use*; D014808:Vitamin D Deficiency / Q000150:complications* / Q000517:prevention & control*
D000305:Adrenal Cortex Hormones; D014807:Vitamin D; D002118:Calcium